UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Platelet Function Monitoring in Patients With Coronary Artery Disease

Journal of the American College of Cardiology, 2007-11, Vol.50 (19), p.1822-1834

2007

Volltextzugriff (PDF)

Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms ( CYP2C19 , ABCB1 , PON1 ), Noncompliance, Diet, Smoking, Co-Medications (Including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet Function

Journal of the American College of Cardiology, 2013-02, Vol.61 (8), p.872-879

2013

Volltextzugriff (PDF)

A Randomized, 2-Period, Crossover Design Study to Assess the Effects of Dexlansoprazole, Lansoprazole, Esomeprazole, and Omeprazole on the Steady-State Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Volunteers

Journal of the American College of Cardiology, 2012-04, Vol.59 (14), p.1304-1311

2012

Volltextzugriff (PDF)

Red cell distribution width as a novel prognostic marker in heart failure : Data from the CHARM program and the duke databank

Journal of the American College of Cardiology, 2007-07, Vol.50 (1), p.40-47

2007

Volltextzugriff (PDF)

Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure: Results From the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) Program

Journal of the American College of Cardiology, 2012-05, Vol.59 (20), p.1785-1795

2012

Volltextzugriff (PDF)

Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure

Journal of the American College of Cardiology, 2012-05, Vol.59 (20), p.1785-1795

2012

Volltextzugriff (PDF)

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction : Results from the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) program

Journal of the American College of Cardiology, 2006-05, Vol.47 (10), p.1997-2004

2006

Volltextzugriff (PDF)

Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction

Journal of the American College of Cardiology, 2001-10, Vol.38 (4), p.1002-1006

2001

Volltextzugriff (PDF)

PATIENT AND PARENT ANXIETY AROUND CHEST PAIN EVALUATION

Journal of the American College of Cardiology, 2023-03, Vol.81 (8), p.1617-1617

2023

Volltextzugriff (PDF)

Increased Platelet Reactivity and Circulating Monocyte-Platelet Aggregates in Patients With Stable Coronary Artery Disease

Journal of the American College of Cardiology, 1998-02, Vol.31 (2), p.352-358

1998

Volltextzugriff (PDF)

Incidence and predictors of hyperkalemia in patients with heart failure : An analysis of the CHARM program

Journal of the American College of Cardiology, 2007-11, Vol.50 (20), p.1959-1966

2007

Volltextzugriff (PDF)

Man Helping Man: In Memoriam: A Tribute to Leonard S. Dreifus, MD

Journal of the American College of Cardiology, 2017-05, Vol.69 (20), p.2570-2572

2017

Volltextzugriff (PDF)

The Incidence of Bradyarrhythmias and Clinical Bradyarrhythmic Events in Patients With Acute Coronary Syndromes Treated With Ticagrelor or Clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) Trial: Results of the Continuous Electrocardiographic Assessment Substudy

Journal of the American College of Cardiology, 2011-05, Vol.57 (19), p.1908-1916

2011

Volltextzugriff (PDF)

Variability of Individual Platelet Reactivity Over Time in Patients Treated With Clopidogrel: Insights From the ELEVATE-TIMI 56 Trial

Journal of the American College of Cardiology, 2014-07, Vol.64 (4), p.361-368

2014

Volltextzugriff (PDF)

Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program

Journal of the American College of Cardiology, 2008-12, Vol.52 (24), p.2000-2007

2008

Volltextzugriff (PDF)

Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization

Journal of the American College of Cardiology, 2004-06, Vol.43 (12), p.2319-2325

2004

Volltextzugriff (PDF)

Man Helping Man

Journal of the American College of Cardiology, 2017-05, Vol.69 (20), p.2570-2572

2017

Volltextzugriff (PDF)

Incidence and Predictors of Hyperkalemia in Patients With Heart Failure

Journal of the American College of Cardiology, 2007-11, Vol.50 (20), p.1959-1966

2007

Volltextzugriff (PDF)

Variability of Individual Platelet Reactivity Over Time in Patients Treated With Clopidogrel

Journal of the American College of Cardiology, 2014-07, Vol.64 (4), p.361-368

2014

Volltextzugriff (PDF)

The association of Seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: A prospective study

Journal of the American College of Cardiology, 2002-10, Vol.40 (8), p.1408-1413

2002

Volltextzugriff (PDF)

Clopidogrel: Linking Evaluation of Platelet Response Variability to Mechanism of Action

Journal of the American College of Cardiology, 2005-08, Vol.46 (4), p.646-647

2005

Volltextzugriff (PDF)

CLOPIDOGREL PHARMACOKINETICS AND PHARMACODYNAMICS VARY WIDELY, INDEPENDENT OF CYP2C19 POLYMORPHISMS, DIET, SMOKING, PROTON PUMP INHIBITORS AND OTHER CO-MEDICATIONS

Journal of the American College of Cardiology, 2011-04, Vol.57 (14), p.E927-E927

2011

Volltextzugriff (PDF)

A RANDOMIZED OPEN-LABEL 2-PERIOD CROSSOVER DESIGN STUDY TO ASSESS THE STEADY-STATE EFFECTS OF DEXLANSOPRAZOLE LANSOPRAZOLE ESOMEPRAZOLE OR OMEPRAZOLE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF CLOPIDOGREL IN HEALTHY SUBJECTS

Journal of the American College of Cardiology, 2011-04, Vol.57 (14), p.E1098-E1098

2011

Volltextzugriff (PDF)

RISK OF CARDIOVASCULAR DEATH AND NON-SUSTAINED VENTRICULAR TACHYCARDIA DETECTED 30-DAYS AFTER ACUTE CORONARY SYNDROME IN THE PLATO (PLATELET INHIBITION AND PATIENT OUTCOMES) TRIAL

Journal of the American College of Cardiology, 2014-04, Vol.63 (12), p.A298-A298

2014

Volltextzugriff (PDF)

The Incidence of Bradyarrhythmias and Clinical Bradyarrhythmic Events in Patients With Acute Coronary Syndromes Treated With Ticagrelor or Clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) Trial

Journal of the American College of Cardiology, 2011-05, Vol.57 (19), p.1908-1916

2011

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Zeitschrift / SerieJournal Of The American College Of Cardiology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(55)

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(55)
Access via ScienceDirect (Elsevier)
(55)
Connected Ingenta
(53)
MEDLINE
(26)
IngentaConnect Journals
(3)

Menü

Weitere Dienste

Einstellungen

Platelet Function Monitoring in Patients With Coronary Artery Disease

Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms ( CYP2C19 , ABCB1 , PON1 ), Noncompliance, Diet, Smoking, Co-Medications (Including Proton Pump Inhibitors), and Pre-Existent Variability in Platelet Function

A Randomized, 2-Period, Crossover Design Study to Assess the Effects of Dexlansoprazole, Lansoprazole, Esomeprazole, and Omeprazole on the Steady-State Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Volunteers

Red cell distribution width as a novel prognostic marker in heart failure : Data from the CHARM program and the duke databank

Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure: Results From the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) Program

Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction : Results from the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) program

Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction

PATIENT AND PARENT ANXIETY AROUND CHEST PAIN EVALUATION

Increased Platelet Reactivity and Circulating Monocyte-Platelet Aggregates in Patients With Stable Coronary Artery Disease

Incidence and predictors of hyperkalemia in patients with heart failure : An analysis of the CHARM program

Man Helping Man: In Memoriam: A Tribute to Leonard S. Dreifus, MD

The Incidence of Bradyarrhythmias and Clinical Bradyarrhythmic Events in Patients With Acute Coronary Syndromes Treated With Ticagrelor or Clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) Trial: Results of the Continuous Electrocardiographic Assessment Substudy

Variability of Individual Platelet Reactivity Over Time in Patients Treated With Clopidogrel: Insights From the ELEVATE-TIMI 56 Trial

Clinical Outcomes According to Baseline Blood Pressure in Patients With a Low Ejection Fraction in the CHARM (Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity) Program

Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization

Man Helping Man

Incidence and Predictors of Hyperkalemia in Patients With Heart Failure

Variability of Individual Platelet Reactivity Over Time in Patients Treated With Clopidogrel

The association of Seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: A prospective study

Clopidogrel: Linking Evaluation of Platelet Response Variability to Mechanism of Action

CLOPIDOGREL PHARMACOKINETICS AND PHARMACODYNAMICS VARY WIDELY, INDEPENDENT OF CYP2C19 POLYMORPHISMS, DIET, SMOKING, PROTON PUMP INHIBITORS AND OTHER CO-MEDICATIONS

A RANDOMIZED OPEN-LABEL 2-PERIOD CROSSOVER DESIGN STUDY TO ASSESS THE STEADY-STATE EFFECTS OF DEXLANSOPRAZOLE LANSOPRAZOLE ESOMEPRAZOLE OR OMEPRAZOLE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF CLOPIDOGREL IN HEALTHY SUBJECTS

RISK OF CARDIOVASCULAR DEATH AND NON-SUSTAINED VENTRICULAR TACHYCARDIA DETECTED 30-DAYS AFTER ACUTE CORONARY SYNDROME IN THE PLATO (PLATELET INHIBITION AND PATIENT OUTCOMES) TRIAL

The Incidence of Bradyarrhythmias and Clinical Bradyarrhythmic Events in Patients With Acute Coronary Syndromes Treated With Ticagrelor or Clopidogrel in the PLATO (Platelet Inhibition and Patient Outcomes) Trial

Aktive Filter

Suchergebnisse filtern